ORAL-CONTRACEPTIVE USE AND LIVER-CANCER

被引：60

作者：

PALMER, JR

ROSENBERG, L

KAUFMAN, DW

WARSHAUER, ME

STOLLEY, P

SHAPIRO, S

机构：

[1] MEM SLOAN KETTERING CANC CTR,DEPT EPIDEMIOL & BIOSTAT,NEW YORK,NY 10021

[2] UNIV PENN,SCH MED,DEPT MED,GEN MED SECT,CLIN EPIDEMIOL UNIT,PHILADELPHIA,PA 19104

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 1989年 / 130卷 / 05期

关键词：

D O I：

10.1093/oxfordjournals.aje.a115420

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：878 / 882

页数：5

共 12 条

[1]

BAUM JK, 1973, LANCET, V2, P926

[2] ESTIMATION OF MULTIPLE RELATIVE RISK FUNCTIONS IN MATCHED CASE-CONTROL STUDIES [J].

BRESLOW, NE ;

DAY, NE ;

HALVORSEN, KT ;

PRENTICE, RL ;

SABAI, C .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1978, 108 (04) :299-307

[3]

CUTLER SJ, 1975, NCI MONOGRAPH, V41

[4] LIVER-CELL ADENOMAS ASSOCIATED WITH USE OF ORAL-CONTRACEPTIVES [J].

EDMONDSON, HA ;

HENDERSON, B ;

BENTON, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (09) :470-472

[5] CANCER OF THE LIVER AND THE USE OF ORAL-CONTRACEPTIVES [J].

FORMAN, D ;

VINCENT, TJ ;

DOLL, R .

BRITISH MEDICAL JOURNAL, 1986, 292 (6532) :1357-1361

[6] HEPATOCELLULAR-CARCINOMA AND ORAL-CONTRACEPTIVES [J].

HENDERSON, BE ;

PRESTONMARTIN, S ;

EDMONDSON, HA ;

PETERS, RL ;

PIKE, MC .

BRITISH JOURNAL OF CANCER, 1983, 48 (03) :437-440

[7]

LINSELL DA, 1976, LIVER CELL CANCER, P1

[8]

NEUBERGER J, 1986, BRIT MED J, V292, P1355, DOI 10.1136/bmj.292.6532.1355

[9] EPIDEMIOLOGY OF HEPATOCELLULAR ADENOMA - ROLE OF ORAL-CONTRACEPTIVE USE [J].

ROOKS, JB ;

ORY, HW ;

ISHAK, KG ;

STRAUSS, LT ;

GREENSPAN, JR ;

HILL, AP ;

TYLER, CW .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (07) :644-648

[10]

Slone D, 1977, EPIDEMIOLOGICAL EVAL, P59

← 1 2 →